MCID: RLP003
MIFTS: 45

Relapsing Fever malady

Categories: Infectious diseases, Rare diseases

Aliases & Classifications for Relapsing Fever

Aliases & Descriptions for Relapsing Fever:

Name: Relapsing Fever 12 56 52 42 14 69

Characteristics:

Orphanet epidemiological data:

56
relapsing fever
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 56  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:13034
ICD10 33 A68 A68.9
ICD9CM 35 087 087.9
MeSH 42 D012061
Orphanet 56 ORPHA91547
MESH via Orphanet 43 D012061
UMLS via Orphanet 70 C0035021
ICD10 via Orphanet 34 A68.0 A68.1 A68.9
UMLS 69 C0035021

Summaries for Relapsing Fever

Disease Ontology : 12 A primary bacterial infectious disease that results_in infection, has material basis in Borrelia, which is transmitted_by tick or transmitted_by body louse.

MalaCards based summary : Relapsing Fever is related to neuropathy and tick-borne relapsing fever, and has symptoms including recurrent fevers An important gene associated with Relapsing Fever is MVK (Mevalonate Kinase), and among its related pathways/superpathways are Photodynamic therapy-induced AP-1 survival signaling. and Cellular Transformation by HTLV1. The drugs Artesunate and chloroquine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and neutrophil, and related phenotype is immune system.

Wikipedia : 71 Relapsing fever is a vector-borne disease caused by infection with certain bacteria in the genus... more...

Related Diseases for Relapsing Fever

Diseases related to Relapsing Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 102)
id Related Disease Score Top Affiliating Genes
1 neuropathy 29.3 CRP TNF
2 tick-borne relapsing fever 12.5
3 louse-borne relapsing fever 12.5
4 epidemic typhus 11.3
5 trench fever 11.1
6 tick infestation 10.7
7 sodoku disease 10.7
8 pediculus humanus corporis infestation 10.7
9 unilateral multicystic dysplastic kidney 10.3 CRP TNF
10 swine influenza 10.3 CRP TNF
11 cataract 10.3 CRP TNF
12 multiple vertebral anomalies unusual facies 10.3 CFH TNF
13 endosalpingiosis 10.2 CFH TNF
14 human immunodeficiency virus infectious disease 10.2 CRP TNF
15 aortic coarctation 10.2 CFH TNF
16 parametritis 10.2 CFH TNF
17 central epithelioid sarcoma 10.2 CRP TNF
18 joint disorders 10.2 CRP TNF
19 cicatricial lagophthalmos 10.2 CRP TNF
20 scalp dermatosis 10.2 CRP TNF
21 myeloid neoplasms associated with pdgfrb rearrangement 10.2 MEFV TNF
22 tau syndrome 10.2 MEFV TNF
23 bile duct signet ring cell carcinoma 10.2 CRP TNF
24 tetanus 10.2 MEFV TNF
25 hypertropia 10.2 CRP TNF
26 anaplastic ganglioglioma 10.2 CRP MEFV
27 cyclotropia 10.2 CRP MEFV
28 hidradenitis 10.1 CRP MEFV
29 lyme disease 10.1
30 esotropia 10.1 CRP MEFV
31 generalized dystonia 10.1 CRP MEFV
32 functional gastric disease 10.1 CRP TNF
33 gonococcal endophthalmia 10.1 MEFV TNF
34 urticaria 10.1 CRP TNF
35 autosomal recessive pericentral pigmentary retinopathy 10.1 TNF TNFRSF1A
36 dermatomycosis 10.1 CRP MEFV TNF
37 histiocytoma 10.1 MEFV TNF
38 benign neonatal seizures 10.1 CRP MEFV TNF
39 strawberry gallbladder 10.1 CRP MEFV TNF
40 myiasis 10.1 CRP MEFV TNF
41 multiple epiphyseal dysplasia 10.1 TNF TNFRSF1A
42 foodborne botulism 10.1 CRP MEFV TNF
43 eating disorder 10.1 CRP MEFV TNF
44 bazex syndrome 10.1 CRP TNFRSF1A
45 juvenile amyotrophic lateral sclerosis with dementia 10.0 TNF TNFRSF1A
46 cerebrum cancer 10.0 CRP TNFRSF1A
47 epimerase deficiency galactosemia 10.0 TNF TNFRSF1A
48 primrose syndrome 10.0 CRP TNFRSF1A
49 oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies 10.0 MEFV TNFRSF1A
50 spondylocostal dysostosis-hypospadias-intellectual disability syndrome 10.0 MEFV TNFRSF1A

Graphical network of the top 20 diseases related to Relapsing Fever:



Diseases related to Relapsing Fever

Symptoms & Phenotypes for Relapsing Fever

UMLS symptoms related to Relapsing Fever:


recurrent fevers

MGI Mouse Phenotypes related to Relapsing Fever:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.17 PURA TNF TNFRSF1A AKAP13 CFH CRP

Drugs & Therapeutics for Relapsing Fever

Drugs for Relapsing Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 257)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Artesunate Approved Phase 4 88495-63-0 6917864 5464098
2
chloroquine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54-05-7 2719
3
Primaquine Approved Phase 4,Phase 3,Phase 2 90-34-6 4908
4
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 564-25-0 54671203
5
Capecitabine Approved, Investigational Phase 4 154361-50-9 60953
6
Irinotecan Approved, Investigational Phase 4,Phase 2,Phase 1 97682-44-5, 100286-90-6 60838
7
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
8
Gatifloxacin Approved, Investigational Phase 4 112811-59-3 5379
9
Itraconazole Approved, Investigational Phase 4 84625-61-6 55283
10
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
11
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
12
Artemether Approved Phase 4 71963-77-4 119380 68911
13
Atovaquone Approved Phase 4 95233-18-4 74989
14
Lumefantrine Approved Phase 4 82186-77-4 6437380
15
Proguanil Approved Phase 4 500-92-5 4923
16
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 50-18-0, 6055-19-2 2907
17
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
18
Interferon beta-1b Approved Phase 4,Phase 2 145155-23-3
19
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
20
Epirubicin Approved Phase 4 56420-45-2 41867
21
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
22
Camptothecin Experimental Phase 4,Phase 1 7689-03-4
23
Docetaxel Approved May 1996, Investigational Phase 4 114977-28-5 148124 9877265
24 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
25 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2,Early Phase 1
26 Anthelmintics Phase 4,Phase 3,Phase 2
27 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
29 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2,Early Phase 1
30 Antimalarials Phase 4,Phase 2,Phase 3
31 Antiparasitic Agents Phase 4,Phase 2,Phase 3
32 Antiprotozoal Agents Phase 4,Phase 2,Phase 3
33 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
34 Chloroquine diphosphate Phase 4,Phase 3,Phase 2 50-63-5
35 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
36 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
37 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
39 Antitubercular Agents Phase 4,Phase 3
40 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
41 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
42 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3
43 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1
44 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2,Phase 1
45 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1
46 topoisomerase I inhibitors Phase 4,Phase 2,Phase 1
47 Fluoroquinolones Phase 4
48 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
49 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3
50 Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 106)
id Name Status NCT ID Phase
1 Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand Unknown status NCT01662700 Phase 4
2 Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours Completed NCT00220168 Phase 4
3 Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis Completed NCT00764114 Phase 4
4 Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever Completed NCT01421693 Phase 4
5 Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection Completed NCT01198236 Phase 4
6 Febrile Urinary Tract Infection Randomized Short Treatment Trial Completed NCT00809913 Phase 4
7 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Completed NCT00336531 Phase 4
8 Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria Completed NCT01150344 Phase 4
9 Advanced Immunological Approach in COPD Exacerbation Completed NCT02417649 Phase 4
10 Life Quality and Mental State in Patients With Breast Cancer Completed NCT01458457 Phase 4
11 Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy Recruiting NCT03177083 Phase 4
12 Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci Recruiting NCT02712307 Phase 4
13 Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer Recruiting NCT02549677 Phase 4
14 The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Burkina Faso: a Cluster Randomized Intervention Study Active, not recruiting NCT02245152 Phase 4
15 The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Mali: a Cluster Randomized Intervention Study Active, not recruiting NCT02323815 Phase 4
16 Scrub Typhus Antibiotic Resistance Trial Not yet recruiting NCT03083197 Phase 4
17 Short Course of Amoxicillin for Erysipelas Terminated NCT01059123 Phase 4
18 Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy Withdrawn NCT02234869 Phase 4
19 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3
20 Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica Unknown status NCT01423591 Phase 3
21 Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever Completed NCT00237016 Phase 2, Phase 3
22 Hyperthermia Combined Brachytherapy in CCU Completed NCT01474356 Phase 3
23 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3
24 Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares Completed NCT01120340 Phase 3
25 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
26 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
27 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
28 To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar Completed NCT00876824 Phase 3
29 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Completed NCT00991146 Phase 3
30 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252732 Phase 3
31 Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Completed NCT01252719 Phase 3
32 Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir Completed NCT01598090 Phase 3
33 PCT and Clinical Algorithm for Determination of Duration of Antibiotics Completed NCT01572831 Phase 3
34 Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria Completed NCT02216123 Phase 3
35 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3
36 Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment Recruiting NCT01376752 Phase 3
37 Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML Recruiting NCT02427919 Phase 2, Phase 3
38 Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy Recruiting NCT02369939 Phase 3
39 Nepal Undifferentiated Febrile Illness Trial Recruiting NCT02773407 Phase 3
40 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Recruiting NCT03117751 Phase 2, Phase 3
41 Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer Recruiting NCT01683864 Phase 2, Phase 3
42 Empirical Versus Preemptive Antifungal Therapy Active, not recruiting NCT01288378 Phase 3
43 Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma Not yet recruiting NCT02238873 Phase 3
44 Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria Not yet recruiting NCT02802501 Phase 3
45 The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome Not yet recruiting NCT02506231 Phase 2, Phase 3
46 Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin Terminated NCT01226992 Phase 2, Phase 3
47 A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation Completed NCT00148148 Phase 2
48 Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis Completed NCT00235989 Phase 2
49 "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia Completed NCT02074657 Phase 2
50 Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) Completed NCT00001359 Phase 2

Search NIH Clinical Center for Relapsing Fever

Cochrane evidence based reviews: relapsing fever

Genetic Tests for Relapsing Fever

Anatomical Context for Relapsing Fever

MalaCards organs/tissues related to Relapsing Fever:

39
Brain, Testes, Neutrophil, Heart, Spleen, Salivary Gland, B Cells

Publications for Relapsing Fever

Articles related to Relapsing Fever:

(show top 50) (show all 539)
id Title Authors Year
1
Louse-borne relapsing fever in Finland in two asylum seekers from Somalia. ( 27859692 )
2017
2
Plasmodium falciparum malaria co-infection with tick-borne relapsing fever in Dakar. ( 28077149 )
2017
3
Hard Tick Relapsing Fever Due to Borrelia Miyamotoi in a Child. ( 27626914 )
2016
4
Correction: Expression of the Tick-Associated Vtp Protein of Borrelia hermsii in a Murine Model of Relapsing Fever. ( 27074024 )
2016
5
Host associations and genomic diversity of Borrelia hermsii in an endemic focus of tick-borne relapsing fever in western North America. ( 27832805 )
2016
6
Louse-borne relapsing fever among East African refugees in Europe. ( 26872415 )
2016
7
Louseborne Relapsing Fever in Young Migrants, Sicily, Italy, July-September 2015. ( 26690334 )
2016
8
Chromosome and Plasmids of the Tick-Borne Relapsing Fever Agent Borrelia hermsii. ( 27284141 )
2016
9
Louse-borne relapsing fever in a refugee from Somalia arriving in Belgium. ( 27356309 )
2016
10
Head Lice of Pygmies Reveal the Presence of Relapsing Fever Borreliae in the Republic of Congo. ( 27911894 )
2016
11
Louseborne Relapsing Fever among East African Refugees, Italy, 2015. ( 26812354 )
2016
12
Tick-Borne Relapsing Fever in Southwest Colorado: A Case Report. ( 27650717 )
2016
13
Relapsing fever in asylum seekers from Somalia arriving in Belgium in August 2015. ( 27112219 )
2016
14
Molecular identification of Borrelia genus in questing hard ticks from Portugal: Phylogenetic characterization of two novel Relapsing Fever-like Borrelia sp. ( 26976475 )
2016
15
Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article. ( 27340042 )
2016
16
Louse-Borne Relapsing Fever (Borrelia recurrentis) in a Somali Refugee Arriving in Italy: A Re-emerging Infection in Europe? ( 27149282 )
2016
17
Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology. ( 27412815 )
2016
18
Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells. ( 27506799 )
2016
19
Tick-Borne Relapsing Fever Outbreak Among a High School Football Team at an Outdoor Education Camping Trip, Arizona, 2014. ( 27430539 )
2016
20
Cyclic-di-GMP binding induces structural rearrangements in the PlzA and PlzC proteins of the Lyme disease and relapsing fever spirochetes: a possible switch mechanism for c-di-GMP-mediated effector functions. ( 27852620 )
2016
21
Tick-Borne Relapsing Fever in Dogs. ( 27353196 )
2016
22
Where Are the Ticks? Solving the Mystery of a Tickborne Relapsing Fever Outbreak at a Youth Camp. ( 27188066 )
2016
23
An Alternative Strategy of Preventive Control of Tick-Borne Relapsing Fever in Rural Areas of Sine-Saloum, Senegal. ( 27430543 )
2016
24
Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015. ( 27188655 )
2016
25
Expression of the Tick-Associated Vtp Protein of Borrelia hermsii in a Murine Model of Relapsing Fever. ( 26918760 )
2016
26
Louse-Borne Relapsing Fever with Meningeal Involvement in an Immigrant from Somalia to Italy, October 2015. ( 26938933 )
2016
27
Borrelia sp. phylogenetically different from Lyme disease- and relapsing fever-related Borrelia spp. in Amblyomma varanense from Python reticulatus. ( 27342652 )
2016
28
Borrelia miyamotoi: A human tick-borne relapsing fever spirochete in Europe and its potential impact on public health. ( 27100337 )
2016
29
Epidemiological Study of Endemic Relapsing Fever in Hamadan Province, West of Iran. ( 28032111 )
2016
30
Chromosome and Linear Plasmid Sequences of a 2015 Human Isolate of the Tick-Borne Relapsing Fever Spirochete, Borrelia turicatae. ( 27417836 )
2016
31
Tick-Borne Relapsing Fever, Southern Spain, 2004-2015. ( 27442975 )
2016
32
Detection and Characterization of the Emerging Relapsing Fever Pathogen, Borrelia miyamotoi, from the Ixodes ricinus Tick in the Rural Trakya (Thrace) Region of Northwestern Turkey. ( 27788060 )
2016
33
Louse-borne relapsing fever (Borrelia recurrentis) in an Eritrean refugee arriving in Switzerland, August 2015. ( 26290486 )
2015
34
Case report: a retrospective serological analysis indicating human exposure to tick-borne relapsing Fever spirochetes in Texas. ( 25856342 )
2015
35
Relapsing Fever Borreliae: A Global Review. ( 26593261 )
2015
36
Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015. ( 26538532 )
2015
37
Tick-borne Relapsing Fever in Children in the North-west of Iran, Qazvin. ( 26445390 )
2015
38
Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite. ( 26490040 )
2015
39
Relapsing Fever: Diagnosis Thanks to a Vigilant Hematology Laboratory. ( 26186517 )
2015
40
Tickborne relapsing fever - United States, 1990-2011. ( 25632952 )
2015
41
Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete. ( 25892254 )
2015
42
Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia. ( 25870274 )
2015
43
Tickborne relapsing fever, Bitterroot Valley, Montana, USA. ( 25625502 )
2015
44
Notes from the Field: Tickborne Relapsing Fever Outbreak at an Outdoor Education Camp - Arizona, 2014. ( 26086637 )
2015
45
Tickborne relapsing fever in southern Iran, 2011-2013. ( 25988268 )
2015
46
Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015. ( 26250069 )
2015
47
Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever. ( 26593262 )
2015
48
Genetic characterization of the human relapsing fever spirochete Borrelia miyamotoi in vectors and animal reservoirs of Lyme disease spirochetes in France. ( 24886071 )
2014
49
A relapsing fever group Borrelia sp. similar to Borrelia lonestari found among wild sika deer (Cervus nippon yesoensis) and Haemaphysalis spp. ticks in Hokkaido, Japan. ( 25108784 )
2014
50
Tick surveillance for relapsing fever spirochete Borrelia miyamotoi in Hokkaido, Japan. ( 25111141 )
2014

Variations for Relapsing Fever

Expression for Relapsing Fever

Search GEO for disease gene expression data for Relapsing Fever.

Pathways for Relapsing Fever

GO Terms for Relapsing Fever

Biological processes related to Relapsing Fever according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.67 CRP MEFV TNF TNFRSF1A
2 regulation of cell proliferation GO:0042127 9.65 PURA TNF TNFRSF1A
3 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.58 AKAP13 TNF TNFRSF1A
4 intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630 9.51 TNF TNFRSF1A
5 establishment of protein localization to plasma membrane GO:0090002 9.49 TNF TNFRSF1A
6 extrinsic apoptotic signaling pathway via death domain receptors GO:0008625 9.46 TNF TNFRSF1A
7 regulation of tumor necrosis factor-mediated signaling pathway GO:0010803 9.43 TNF TNFRSF1A
8 negative regulation of lipid storage GO:0010888 9.32 CRP TNF
9 positive regulation of ceramide biosynthetic process GO:2000304 9.26 TNF TNFRSF1A
10 death-inducing signaling complex assembly GO:0071550 9.16 TNF TNFRSF1A
11 negative regulation of inflammatory response GO:0050728 9.13 MEFV MVK TNFRSF1A
12 regulation of establishment of endothelial barrier GO:1903140 8.62 TNF TNFRSF1A

Sources for Relapsing Fever

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....